Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Psychiatry
  4. Substance Use Disorder
  5. Treatment

Treatment

  • ADHD (74)
  • Agitation (1)
  • Anxiety (28)
  • Bipolar Disorder (15)
  • Depression (269)
  • Mental Health (27)
  • Resources (176)
  • Schizophrenia (60)
  • Sleep Disorders (91)
  • Substance Use Disorder (238)
    • Alcohol (7)
    • Drug Testing (7)
    • Drugs of Abuse (188)
    • Treatment (66)
31 - 45 of 66 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Think of Lucemyra as Similar to Clonidine for Opioid Withdrawal September 2018
Other: Naloxone for Overdose Prevention (Intranasal) June 2018
Other: Naloxone for Overdose Prevention (Intramuscular) June 2018
Article: Streamline Processes for Providing Naloxone June 2018
PL Voices: Expanding Access to Naloxone June 2018
Article: Compare Sublocade to Other Buprenorphine Forms for Opioid Dependence March 2018
Article: Explain When Naltrexone Might Be Appropriate for Opioid Dependence January 2018
Article: Help Pregnant Women With Appropriate Opioid Use November 2017
Archive: Conversation Starter: Chronic Opioid Use November 2017
Article: Expect Less Concern Over Psychiatric Effects With Chantix February 2017
PL Voices: Psychiatric Effects of Varenicline and Bupropion in Smoking Cessation February 2017
Other: Chantix and Zyban Mental Health Side Effects Revised February 2017
Article: Be Ready to Help More Patients Use Buprenorphine/Naloxone January 2017
Article: Include the Probuphine Implant in Patient Profiles August 2016
Other: Preparing and Prescribing Naloxone Rescue Kits January 2016
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved